Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Completed 4Unknown 2

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 3NET 1Endocrine 1

Conditions

Breast Neoplasms 2Neuroendocrine Tumors 1Inflammatory Breast Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1436Paclitaxel 1342Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1135Bevacizumab 1071Fluorouracil 907Doxorubicin 805Dexamethasone 755Rituximab 745Capecitabine 736Oxaliplatin 710pembrolizumab 700Etoposide 679Irinotecan 641Filgrastim 624Nivolumab 588Cytarabine 587Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 437

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × 89Zr-bevacizumab × Clear all
NCT01894451 2019-12-12

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Completed
2 enrolled
Breast

Inflammatory Breast Neoplasms

NCT01081613 2012-09-06

Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)

University Medical Center Groningen

Completed
7 enrolled
Breast

Breast Neoplasms

NCT01338090 2012-04-03

NETPET

University Medical Center Groningen

Completed
14 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT00991978 2012-03-30

VEGF Early Imaging for Breast Cancer

University Medical Center Groningen

Phase EARLY_PHASE1 Completed
23 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡